Daunorubicin Decreases Long-Term Cardiomyopathy Risk in Childhood Cancer Survivors episode artwork

EPISODE · Mar 12, 2019 · 10 MIN

Daunorubicin Decreases Long-Term Cardiomyopathy Risk in Childhood Cancer Survivors

from Oncology Learning Network · host HMP Global

Daunorubicin Decreases Long-Term Cardiomyopathy Risk in Childhood Cancer Survivors by HMP Global

Episode metadata supplied by the publisher feed · Published Mar 12, 2019

Embed this episode

Ready to play

Daunorubicin Decreases Long-Term Cardiomyopathy Risk in Childhood Cancer Survivors

0:00 10:58

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Learning Network?

This episode is 10 minutes long.

When was this Oncology Learning Network episode published?

This episode was published on March 12, 2019.

Can I download this Oncology Learning Network episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!